Arca
Skip to content
Tools
Tools

PIKFYVE: 1-phosphatidylinositol 3-phosphate 5-kinase

Dual specificity kinase implicated in myriad essential cellular processes such as maintenance of endomembrane homeostasis, and endocytic-vacuolar pathway, lysosomal trafficking, nuclear transport, stress- or hormone-induced signaling and cell cycle progression.

  • Drugs that act on it: 1
  • Approved: 0
  • In phases 1 to 3: 1
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on PIKFYVE, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 1

Approved0

    Phase 30

      Phase 21

      • Apilimod

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        ApilimodPhase 2Synta Pharmaceuticals Corp.Small moleculeInhibitor1-phosphatidylinositol 3-phosphate 5-kinase inhibitor0

        Diseases most associated with it

        Open Targets association score, 0 to 1; all associations
        • Fleck corneal dystrophy0.75
        • Neurodegenerative disease0.56
        • Lysosomal storage disease0.51
        • Alzheimer disease0.50
        • Parkinson disease0.50
        • Hereditary disease0.20
        • Muscular disease0.15
        • Preeclampsia0.14
        • Mixed connective tissue disease0.13
        • Response to xenobiotic stimulus0.13
        • Poisoning0.13

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1938222, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. Gene name, function (UniProt Q9Y2I7, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.